After a radical downsizing, Teva beefs up US R&D campus; Tiaki recruits Suzanne Bruhn for the helm
→ Eighteen months after setting in motion a draconian reorganization aimed at shuttering facilities and laying off 14,000 staffers, Teva says it is adding to its footprint at their US R&D center in West Chester, PA. The pharma company says it’s snapped up 3 buildings in the office park on Brandywine Parkway for its North American R&D HQ, where they’re focused on biologics development and manufacturing. By the end of this year Teva says that they’ll have a staff of 650 on their campus occupying 6 buildings and 314,000 square feet of space.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.